Signal Transduction by IL-2 and its Receptors as Target in Treatment of Rheumatoid Arthritis

Publisher： Bentham Science Publishers

E-ISSN： 1875-5917|5|1|41-50

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.5, Iss.1, 2005-01, pp. : 41-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IL-33: a promising therapeutic target for rheumatoid arthritis?

By Yuan Feng-Lai   Li Xia   Lu Wei-Guo   Li Cheng-Wan   Xu Rui-Sheng   Dong Jian  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 5, 2011-05 ,pp. : 529-534

Informa Healthcare

Access to resources Recommend Favorite

IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis

By Gabay C.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 1, 2000-01 ,pp. : 113-127

Informa Healthcare

Access to resources Recommend Favorite

Signal Transduction via Cannabinoid Receptors

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 6, 2009-01 ,pp. : 422-431

Bentham Science Publishers

Access to resources Recommend Favorite

Signal Transduction Activated by Cannabinoid Receptors

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 7, 2005-07 ,pp. : 619-630

Bentham Science Publishers

Access to resources Recommend Favorite

Leflunomide for the treatment of rheumatoid arthritis

By Miceli-Richard Corinne   Dougados Maxime  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite